Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants. - Wikidata - wikimedia - TriplyDB

Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.

Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.

http://www.wikidata.org/entity/Q35586877

about

Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection Chikungunya vaccines in development Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus Recent Progress toward Engineering HIV-1-Specific Neutralizing Monoclonal Antibodies Viperin restricts chikungunya virus replication and pathology.A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island.Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing.Suramin Inhibits Chikungunya Virus Entry and Transmission Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.Intercellular Extensions Are Induced by the Alphavirus Structural Proteins and Mediate Virus Transmission Identification of Functional Determinants in the Chikungunya Virus E2 Protein.Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development An essential role of antibodies in the control of Chikungunya virus infection.Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.Spatial and Temporal Analysis of Alphavirus Replication and Assembly in Mammalian and Mosquito Cells.Use of human monoclonal antibodies to treat Chikungunya virus infection.Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.Clinical, Serological and Virological analysis of 572 chikungunya patients during the years 2010-2013 from India.Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using panel of peptides derived from envelope protein for serodiagnosis.Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission.Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection.Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community.Miltefosine inhibits Chikungunya virus replication in human primary dermal fibroblasts.Human-Like Neutralizing Antibodies Protect Mice from Aerosol Exposure with Western Equine Encephalitis Virus.The Alphavirus Exit Pathway: What We Know and What We Wish We Knew.

P2860

Q24276414-D28D0957-B4B4-426F-A5CF-D321D9E1579D Q24289014-3E51226B-0EB9-4C64-AB6F-E8970E077A51 Q24701766-8F449F84-AB93-417F-9A29-D8FF90509C5A Q24701786-9D65751D-D046-4E1A-A604-7FAE18D3851F Q24701792-013CF1F1-8094-45E1-9893-699951BE7DD3 Q26700081-05C55266-94EE-4975-AE18-612F189C5991 Q27013018-B141A488-1A1C-4CE0-A123-355F0D6C14AD Q27335008-3DABF449-F930-4E37-8663-35F35F01DAE6 Q28068946-C30F272B-ED9B-4443-9777-C294A1D91078 Q28504479-46570840-CBEC-410B-9308-254C93F79EF6 Q28533408-79B6B973-6E96-4707-A78D-8BD4094393F3 Q35078457-0F885BC2-1825-4E1C-B5BC-0AE3C32A1BBF Q35238179-E95BDD03-82C9-4EA9-B19C-39D1A80054C1 Q35574887-7A434D58-1807-47E0-A1A7-093891149D3B Q35711583-4D1865F9-EAD8-4769-9570-84B1D71EF352 Q35850197-B373F7B7-97EB-44D7-9AB0-086E8292E08D Q36225228-4BD7F940-DDC7-404F-BE9B-9F0B3FF2704B Q36257616-D4C20100-72F7-4785-93E0-4DF88B46C5B3 Q36397446-EF65604D-B013-4177-B7CC-E54B0A527424 Q36914762-AEEFF16E-0789-4CF4-ACA3-76C19A2EFB75 Q37214518-3C91B665-C815-45B6-BEF6-D1D450142887 Q38329445-BEC57FF4-012B-4B57-8FE8-887914073292 Q38716498-36E8E266-C615-4474-AC30-895DADEA1D8A Q39012242-1A8CFAE1-53BB-4187-ACA7-71D2160E5051 Q39013750-664414C9-E8B1-4F55-9BA6-96CCD059A385 Q40062417-9E8E1F86-2E6B-4C59-814D-445587E489C2 Q40077669-25D404B3-8D3A-4872-AE2A-A82C06033CD8 Q40232847-1D209A88-615B-4928-9106-A1A40F3FB100 Q40922578-C8EBC482-0E13-4CBC-9A36-3991C47E9AFB Q42923192-E8FE2092-E967-426C-B095-FB8BE9F983F3 Q48095971-01342672-8D55-4147-906C-21722944D641 Q54111086-646FE6CA-96B3-4A7D-8A0C-9D87A377BC5B Q54247380-6C10AD85-CCDA-46A9-90AA-92291D1A5849 Q54268571-8C4875D4-FBA3-4D22-B97C-A1F220E1A71B

P2860

Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.

http://www.wikidata.org/entity/Q35586877

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Chikungunya virus neutralizati ...... human antibody-escape mutants.

@ast

Chikungunya virus neutralizati ...... human antibody-escape mutants.

@en

type

label

Chikungunya virus neutralizati ...... human antibody-escape mutants.

@ast

Chikungunya virus neutralizati ...... human antibody-escape mutants.

@en

prefLabel

Chikungunya virus neutralizati ...... human antibody-escape mutants.

@ast

Chikungunya virus neutralizati ...... human antibody-escape mutants.

@en

P1433

Q35586877-193C4AC7-C086-4590-9241-1B7E66E16F05

P1476

Q35586877-E5179F79-8651-46F0-93DB-C28C2294D4CB

P2093

Q35586877-011323AE-82AC-4ED6-8140-4DDD7B7DD8AE

Q35586877-0945B239-207C-436D-BBAA-77DD313214C8

Q35586877-2254B23D-C3C0-4123-ACBE-7EFF5BA21F40

Q35586877-6059DE50-2235-4884-9985-242C5FC77603

Q35586877-6F2361BE-1251-4B6F-8A05-26BA77F75D20

Q35586877-992A9245-E495-4CCB-B7FF-E44570AD4409

Q35586877-A4974BD0-4D39-416B-BF14-5BA4B221BEE2

Q35586877-BCE28A1F-A39B-4AD8-BD65-59622C6DC82F

Q35586877-C407B9C0-BF01-4D81-BB6E-7747A0086F3C

Q35586877-F4AF909A-C582-4291-B134-B403C11A05EC

P2860

Q35586877-0661CB3B-B627-448D-A579-21C0901880AF

Q35586877-0B8E8AEC-5708-4777-95FB-8FA158D46381

Q35586877-0CE698AE-7C94-4E54-8C77-EF5C828B1320

Q35586877-0D41D5D1-E98F-496C-A42F-5BDA48E95EA7

Q35586877-1135FCFA-49ED-4997-9AD4-AFC282D53798

Q35586877-11922477-0EBC-40B4-96ED-E7DA0C2B472F

Q35586877-18E485EC-9DD1-42C3-B190-5F837E386D4A

Q35586877-1B755EBA-7575-4687-A6C3-3C1920E4C9DF

Q35586877-1BEE5CEE-320B-4854-B1BB-A8F91954338F

Q35586877-21D9D9D2-4E97-417C-BE93-935287545349

P304

Q35586877-AE36CB65-E142-48E8-BF8D-CC191BA6B306

P31

Q35586877-A93C494B-277D-4E3B-8135-327BD55C24FA

P356

Q35586877-1AE91664-67BC-4C20-BE80-E0EAAF5215E8

P433

Q35586877-D5AFECD7-089E-49EC-9E93-6C9DC23C8D5E

P478

Q35586877-D71146F8-A008-4688-90B2-EBCE5B43F65F

P50

Q35586877-0C7954FC-35B9-419E-9758-28588D8545FD

Q35586877-18925FCD-F63A-4827-B4B1-76AB970626EF

Q35586877-8B8DB9D4-A5C0-42FB-8D7F-DDF72E3E43C5

Q35586877-9334018D-5076-49D1-912D-D0D8FE01C1AC

P5008

Q35586877-1BACAFEA-FB64-46D1-88E0-9AF1A4431E21

P577

Q35586877-CB707F57-545B-4B62-9C15-23B24C676329

P5875

Q35586877-FC2AA606-BD6A-4969-8D0F-4A6AB1EE6A61

P698

Q35586877-2BF7E35B-B8F7-4CE8-ACF1-D76B74BA6474

P921

Q35586877-0F29998C-2633-4732-B2A5-E1E179E24859

Q35586877-90A08729-E918-426B-B2A0-A02D7017F99D

P932

Q35586877-C9BDFB89-711F-4C83-9A5E-BFB25BF830D0

P356

JOURNAL.PPAT.1002390

P1433

P1476

Chikungunya virus neutralizati ...... human antibody-escape mutants.

@en

P2093

Celine Prakash

http://www.w3.org/2001/XMLSchema#string

Cheng-I Wang

http://www.w3.org/2001/XMLSchema#string

Chia Yin Lee

http://www.w3.org/2001/XMLSchema#string

Cui Lin

http://www.w3.org/2001/XMLSchema#string

Esther G L Koh

http://www.w3.org/2001/XMLSchema#string

Laurent Renia

http://www.w3.org/2001/XMLSchema#string

Lucile Warter

http://www.w3.org/2001/XMLSchema#string

Raymond T P Lin

http://www.w3.org/2001/XMLSchema#string

Wen Huang

http://www.w3.org/2001/XMLSchema#string

Wendy W L Lee

http://www.w3.org/2001/XMLSchema#string

P2860

A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease

Avoiding the void: cell-to-cell spread of human viruses

Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages

Viral mutation rates

Mutation rates among RNA viruses

Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion

Sindbis virus attachment: isolation and characterization of mutants with impaired binding to vertebrate cells

Arbovirus evolution in vivo is constrained by host alternation

Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection

A conformational change in Sindbis virus glycoproteins E1 and E2 is detected at the plasma membrane as a consequence of early virus-cell interaction.

P304

e1002390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1002390

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Benoit Malleret

P5008

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51855889

http://www.w3.org/2001/XMLSchema#string

P698

22144891

http://www.w3.org/2001/XMLSchema#string

P921

Chikungunya virus

chikungunya virus transmission

P932

3228792

http://www.w3.org/2001/XMLSchema#string